EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD Stock (OTC: EVBSF)

Latest news for EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD (OTC:EVBSF) Stock

EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD

WIIM

TRNR

Interactive Strength shares are trading higher after the company received a letter stating that the Nasdaq Hearings Panel granted its request for continued listing on the Nasdaq Stock Market.

Biotech

Earnings

News

Guidance

Health Care

General

TCRX

TScan Therapeutics' Cash, Cash Equivalents, And Marketable Securities Of $297.7M Continue To Fund Operations Into The Fourth Quarter Of 2026

Mega Matrix Corp. ("MPU" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPU#NYSE">MPU</a>), today announced that FlexTV, its short drama streaming platform, has ranked No.3&nbsp;in the App Store Entertainment Chart (Free Apps, Indonesia) and Google Play Entertainment App (Free Apps, Indonesia) as of August 12, 2024.
&nbsp;
This accomplishment further solidifies FlexTV's leading position in the Asian market and demonstrates its widespread popularity on a global scale.

Mega Matrix's FlexTV Ranks No.3 on Indonesia's App Store and Google Play

TScan Therapeutics Q2 2024 GAAP EPS $(0.28) Beats $(0.29) Estimate, Sales $536.000K May Not Be Comparable To $2.419M Estimate

B of A Securities analyst Shaun Kelley upgrades Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>) from Neutral to Buy and raises the price target from $145 to $155.

Upgrades

Price Target

Analyst Ratings

CHDN

B of A Securities Upgrades Churchill Downs to Buy, Raises Price Target to $155

Contracts

SPNS

Sapiens Announces Sapiens ReinsurancePro Contract With Society Insurance; Terms Not Disclosed

For the full year 2024, the Company expects total operating expenses to be between $78.0 million and $80.0 million.

STIM

Neuronetics Forecasts Q3 revenue of $18.5M-$19.5M Versus Consensus Of $20.115M, With 2024 Sales Of $78M-$80M Compared To Consensus Of $79.15M

JBLU

JetBlue shares are trading lower after the company announced a $400 million convertible senior notes offering.

JetBlue Airways shares are trading lower after the company announced a $400 million convertible senoir notes offering.

HC Wainwright &amp; Co. analyst Matthew Caufield initiates coverage on LENZ Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) with a Buy rating and announces Price Target of $38.

Initiation

LENZ

HC Wainwright & Co. Initiates Coverage On LENZ Therapeutics with Buy Rating, Announces Price Target of $38

B of A Securities analyst Jeffrey Spector downgrades Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) from Buy to Neutral and announces $128 price target.

Downgrades

B of A Securities Downgrades Prologis to Neutral, Announces $128 Price Target

Wells Fargo analyst Neil Kalton downgrades Algonquin Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) from Overweight to Equal-Weight and lowers the price target from $8.5 to $6.

Wells Fargo Downgrades Algonquin Power to Equal-Weight, Lowers Price Target to $6

BEKE

KE Holdings shares are trading higher after the company reported better-than-expected Q2 financial results and increased its repurchase authorization.

Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) stock is trading lower on Monday, triggered by capital outflows.
Taiwan&#8217;s foreign exchange reserves dropped by $1.6 billion in July, primarily due to foreign money exiting the market during recent global sell-offs, Reuters reports.
However, Taiwan Semiconductor continues to dominate Taiwan&#8217;s stock market, significantly contributing to the country&#8217;s impressive performance this year.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/24/08/40190491/whats-going-on-with-taiwan-semi-stock-on-tuesday" rel="noreferrer noopener">Nvidia and Taiwan Semiconductor Hit Production Snags, Raising Concerns About AI Boom</a>
The MSCI Taiwan Index has soared by nearly 28% year-to-date, doubling the S&amp;P 500&#8217;s growth.
Taiwan Semiconductor, which has seen an almost 80% rally this year, accounts for over half of the MSCI Taiwan Index, and its market cap now exceeds the entire economy of Taiwan.
The tech giant&#8217;s success is part of a broader AI-driven market enthusiasm, with other companies like Hon Hai Precision Industry also benefiting. Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) supplier Hon Hai, doing business as Foxconn, which holds a 5% weight in the MSCI Taiwan Index, has seen its shares rise by 62% this year, according to Reuters.
Taiwan Semiconductor reported 45% revenue growth in July. <a target="_blank" href="https://www.benzinga.com/news/24/08/40282876/whats-going-on-with-nvidia-stock-on-friday" rel="noreferrer noopener">Analysts told Bloomberg</a> that they expect Taiwan Semiconductor&#8217;s third-quarter revenue to grow by 37% or more.
Investors can gain exposure to Taiwan Semiconductor through iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) and First Trust NASDAQ Technology Dividend Index Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDIV#NASDAQ">TDIV</a>).
Price Action: TSM shares traded lower by 0.26% at $166.69 premarket at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by Jack Hong via Shutterstock

Government

Regulations

Tech

Media

AAPL

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TDIV

What's Going On With Taiwan Semiconductor Stock On Monday?

KeyCorp shares are trading higher after Scotiabank acquired a 14.9% stake in the company.

The transaction creates a vertically-integrated organization capable of providing access to mental health treatment with significant scale in the U.S. The transaction offers multiple strategic benefits for Neuronetics and its customers, including increased brand awareness for NeuroStar, more consistent delivery of best practices, and the ability to offer a variety of positive benefits for all NeuroStar customers. Beyond the strategic benefits, the transaction is expected to create compelling financial benefits, including increased revenue scale and a strong growth trajectory, material cost synergies, an accelerated path to profitability, and a bolstered balance sheet.
&nbsp;
&nbsp;
Beyond the strategic benefits, the transaction is expected to create compelling financial benefits, which include:
<ul>
<li>Increased Revenue Scale and Strong Growth Trajectory. In fiscal year 2023, the pro forma revenue of the combined company would have been approximately $145 million, effectively doubling the scale of the stand-alone businesses. Additionally, the combined company expects mid-teens year over year revenue growth in fiscal years 2025 and 2026.</li>
<li>Material Cost Synergies. Through the optimization of marketing spend as well as back office functions, the combined company expects to be able to realize at least $15 million of annualized cost savings, the majority of which will be realized in fiscal year 2025.</li>
<li>Accelerated Path to Profitability. Coming as a result of strong expected revenue growth and the realization of cost synergies, the combined company anticipates to be Adjusted EBITDA positive and also cash flow positive for the full fiscal year 2025, excluding one-time costs related to the transaction.</li>
<li>Bolstered Balance Sheet. As a result of the pre-transaction conversion of Greenbrook's debt into common shares, in combination with the scale of the business post-acquisition, the consolidated company will be able to leverage an improved balance sheet to execute on its long-term growth strategy.</li>
</ul>

Neuronetics Agreed To Acquire Greenbrook TMS In An All-stock Transaction

B of A Securities analyst John Murphy maintains American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) with a Underperform and raises the price target from $7 to $7.5.

B of A Securities Maintains Underperform on American Axle & Mfg Hldgs, Raises Price Target to $7.5

Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCRX#NASDAQ">PCRX</a>) with a Buy and lowers the price target from $43 to $22.

PCRX

Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $22

Wells Fargo analyst Finian O'Shea upgrades Goldman Sachs BDC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSBD#NYSE">GSBD</a>) from Underweight to Equal-Weight and lowers the price target from $14 to $12.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD

News

Latest news for EVERBRIGHT SECS CO LTD by EVERBRIGHT SECS CO LTD (OTC:EVBSF) Stock